COMMUNIQUÉS West-GlobeNewswire

Nephros Announces Preliminary Financial Results for First Quarter 2019
08/04/2019
Anticipates $1.7 Million Revenue; Year-over-Year Growth Exceeds 75% SOUTH ORANGE, NJ, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device and commercial [...]
Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0
08/04/2019
REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of [...]
American Cannabis Market Fueled By Positive Legislation
08/04/2019
SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
Clearside Biomedical Appoints Dr. George Lasezkay as Interim CEO
08/04/2019
ALPHARETTA, Ga., April 08, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Trillium Therapeutics to Present at Investor Conferences in April
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that the [...]
Kymab Appoints Pharmaceutical Veteran Simon Sturge as Chief Executive Officer
08/04/2019
Kymab Appoints Pharmaceutical Veteran Simon Sturge as Chief Executive Officer Cambridge, UK; April 8, 2019 : Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, today announced the [...]
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
08/04/2019
— Conference call to be held today at 8:30 a.m. Eastern Time — BOSTON, Mass. and MALVERN, Penn., April 08, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) and Ocugen, Inc., a privately held clinical- [...]
Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau™ and BOTOX® in Aesthetic Surgery Journal
08/04/2019
Primary Endpoint of Non-Inferiority Achieved with Responder Rates* of 87.2% for Jeuveau™, 82.8% for BOTOX ® and 4.2% for Placebo at Day 30 Secondary and Exploratory Analyses Unveil Additional Information about Jeuveau™ [...]
Neon Therapeutics Announces Completion of Enrollment in Phase 1b NT-002 Clinical Trial of NEO-PV-01 in Metastatic Non-Small Cell Lung Cancer
08/04/2019
First Clinical Trial to Evaluate the Potential of the Personal Neoantigen Vaccine NEO-PV-01 in Combination with Standard of Care in First-Line Metastatic NSCLC Treatment Setting CAMBRIDGE, Mass., April 08, 2019 (GLOBE [...]
Inspire Medical Systems, Inc. Announces Three New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans
08/04/2019
MINNEAPOLIS, April 08, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Emerald Health Therapeutics Receives Standard Processing License for Verdélite Facility in Quebec
08/04/2019
New license gives Verdélite ability to extract and process cannabis for the development and manufacture of next-generation cannabis products VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials
08/04/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]
Auxly Announces Receipt of Cultivation and Processing Licences for Robinsons Cannabis Facility
08/04/2019
VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“ [...]
ContraFect Announces Publication of Exebacase Data in Antimicrobial Agents and Chemotherapy Journal
08/04/2019
Data demonstrates that exebacase activates key host factors in human blood to potentiate methicillin-resistant Staphylococcus aureus bacteriolysis YONKERS, N.Y., April 08, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation [...]
Madrigal Pharmaceuticals to Present Additional Analyses of Data from The Phase 2 NASH Study with MGL-3196 (resmetirom) at The International Liver Congress™ 2019
08/04/2019
-- MRI-PDFF response (≥30% reduction in hepatic fat) at 12 weeks correlated with reduction in the ballooning and inflammation components of NAS and was predictive of NASH resolution on liver biopsy at 36 weeks -- -- The [...]
Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.
08/04/2019
DELRAY BEACH, Fla., April 08, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, [...]
XOMA Acquires Royalty Rights to Five Hematology Candidates
08/04/2019
EMERYVILLE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today it has agreed to acquire the rights to potential royalty payments and a portion of the potential milestone payments [...]
Arrayit Corporation Announces Allergy Testing Services Evaluation Expansion by a Major Pharmacy Retailer
08/04/2019
Sunnyvale, April 08, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that its proprietary finger stick allergy testing services continue to be [...]
ViroGates notice to convene the annual general meeting on 25 April 2019
08/04/2019
We hereby convene the annual general meeting of ViroGates A/S on 25 April 2019 at 5:00 pm at Comwell Holte, Kongevejen 495A, DK-2840 Holte. The agenda and full proposals can be read in the attached document. For further [...]

Pages